Page last updated: 2024-08-17

cycloserine and Body Weight

cycloserine has been researched along with Body Weight in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (30.00)	18.7374
1990's	3 (30.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gray, SJ; Guzman, AM; Hawkins-Salsbury, JA; Hunter, DA; Jiang, X; Li, Y; Ory, DS; Qin, EY; Reddy, AS; Sands, MS; Shea, L	1
Geller, DA; Henin, A; Lewin, AB; McGuire, J; Micco, J; Murphy, TK; Mutch, PJ; Small, BJ; Sprich, S; Storch, EA; Wilhelm, S	1
Biesiada, H; Biswas, S; LeVine, SM; Williams, TD	1
Haskell, BE; Wallnöfer, U	1
DeHaven, JI; Koukol, SC; Lamm, DL; Riggs, DR	1
Moryl, E; Papp, M	1
Denisova, L; Miller, SL	1
Biswas, S; LeVine, SM	1
Pyle, MM	1

Reviews

1 review(s) available for cycloserine and Body Weight

Article	Year
Ethambutol and viomycin. The Medical clinics of North America, 1970, Volume: 54, Issue:5 Topics: Adolescent; Aged; Body Weight; Child, Preschool; Cycloserine; Deafness; Ethambutol; Female; Humans; Isoniazid; Kidney Diseases; Male; Mycobacterium bovis; Mycobacterium Infections; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Pulmonary; Viomycin; Vision Disorders; Visual Acuity	1970

Trials

2 trial(s) available for cycloserine and Body Weight

Article	Year
Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA psychiatry, 2016, Aug-01, Volume: 73, Issue:8 Topics: Adolescent; Amygdala; Body Weight; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Dose-Response Relationship, Drug; Female; Humans; Male; Obsessive-Compulsive Disorder; Receptors, N-Methyl-D-Aspartate; Treatment Outcome	2016
A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months. Tubercle, 1975, Volume: 56, Issue:3 Topics: Antibody Formation; Body Weight; Clinical Trials as Topic; Cycloserine; Drug Combinations; Drug Resistance; Ethambutol; Ethionamide; Fever; Follow-Up Studies; Humans; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary	1975

Article

Year

Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.

JAMA psychiatry, 2016, Aug-01, Volume: 73, Issue:8

Topics: Adolescent; Amygdala; Body Weight; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Dose-Response Relationship, Drug; Female; Humans; Male; Obsessive-Compulsive Disorder; Receptors, N-Methyl-D-Aspartate; Treatment Outcome

2016

A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months.

Tubercle, 1975, Volume: 56, Issue:3

Topics: Antibody Formation; Body Weight; Clinical Trials as Topic; Cycloserine; Drug Combinations; Drug Resistance; Ethambutol; Ethionamide; Fever; Follow-Up Studies; Humans; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary

1975

Other Studies

7 other study(ies) available for cycloserine and Body Weight

Article	Year
Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, Apr-22, Volume: 35, Issue:16 Topics: Animals; Body Weight; Bone Marrow Transplantation; Brain; Combined Modality Therapy; Cycloserine; Cytokines; Female; Galactosylceramidase; Genetic Therapy; Leukodystrophy, Globoid Cell; Male; Mice; Mice, Inbred Strains; Motor Skills; Myelin Sheath; Psychosine; Sciatic Nerve	2015
Substrate reduction intervention by L-cycloserine in twitcher mice (globoid cell leukodystrophy) on a B6;CAST/Ei background. Neuroscience letters, 2003, Aug-14, Volume: 347, Issue:1 Topics: Animals; Body Weight; Cycloserine; Enzyme Inhibitors; Leukodystrophy, Globoid Cell; Longevity; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Oxo-Acid-Lyases; Psychosine	2003
The effect of cycloserine on chick growth. Poultry science, 1967, Volume: 46, Issue:4 Topics: Animal Feed; Animals; Body Weight; Chickens; Cycloserine; Linseed Oil; Male; Pyridoxine	1967
Drug therapy of bacillus Calmette-Guérin sepsis. Urological research, 1995, Volume: 22, Issue:6 Topics: Animals; Body Weight; Cycloserine; Drug Combinations; Isoniazid; Mice; Mice, Inbred C3H; Mycobacterium bovis; Prednisone; Rifampin; Survival Analysis; Tuberculosis	1995
Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression. European journal of pharmacology, 1996, Dec-05, Volume: 316, Issue:2-3 Topics: Animals; Body Weight; Carboxylic Acids; Cycloserine; Depressive Disorder; Disease Models, Animal; Drinking; Male; Rats; Rats, Wistar	1996
Cycloserine-induced decrease of cerebroside in myelin. Lipids, 1998, Volume: 33, Issue:4 Topics: Animals; Antibiotics, Antitubercular; Body Weight; Brain; Brain Chemistry; Cycloserine; Female; Galactosylceramides; Myelin Sheath; Organ Size; Phospholipids; Proteins; Rats; Rats, Wistar	1998
Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy. Pediatric research, 2002, Volume: 51, Issue:1 Topics: Animals; Body Weight; Bone Marrow Transplantation; Cycloserine; Glial Fibrillary Acidic Protein; Immunohistochemistry; Leukodystrophy, Globoid Cell; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Rhombencephalon	2002